Meridian Bioscience, Inc. (VIVO) on Tuesday reaffirmed its adjusted earnings guidance for the full-year 2018 in the range of $0.69 and $0.72 per share and net revenues between $209 million and $214 million.
from RTT - Earnings https://ift.tt/2mZIP3D
via IFTTT
No comments:
Post a Comment